K. F. Bradstock

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

Emmanuelle Tavernier, JM Boiron, Françoise Huguet et al. · Leukemia · 2007 · 255 citations

Medicine, Oncology, Chemotherapy +8

USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA

H. G. Prentice, George Janossy, D. Skeggs et al. · The Lancet · 1982 · 219 citations

Life Sciences, Hematology, Immunology +8

Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro

Julius Juaréz, K. F. Bradstock, David Gottlieb et al. · Leukemia · 2003 · 177 citations

Medicine, Oncology, Pharmacology +10

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy

Biju George, Nalini Pati, Nicole Gilroy et al. · Transplant Infectious Disease · 2010 · 176 citations

Medicine, Hematology, Immunology +17

Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group

K. F. Bradstock, Jane Matthews, Elizabeth M. Benson et al. · Blood · 1994 · 124 citations · Full text

Medicine, Hematology, Oncology +15